Printer Friendly

NEPTUNE TECHNOLOGIES & BIORESSOURCES UNVEIL GLUCOSAMINE.

Neptune Technologies and Bioressources Inc., Laval, QC, has launched a new Glucosamine/NKO(TM) blend through a strategic partnership with Koyo Chemical Co., Ltd.

This new Joint Health Complex, to be launched in Japan, is a powerful anti-inflammatory and cartilage regenerating formulation comprised with Glucosamine and Neptune Krill Oil (NKO(TM)). The partnership also includes an agreement by which Neptune will exclusively introduce the Joint Health Complex to the North American and European markets.

"We are pleased with our agreement with Neptune, allowing us to utilize NKO(TM) as our main ingredient in our Joint Health Complex product. NKO(TM), by its anti-inflammatory potency will enhance the Glucosamine benefits for our Japanese consumers. They'll definitely embrace our new Joint Health Complex with NKO(TM) inside" said Taro Terashi, president at Koyo Chemical Co., Ltd. "Additionally our company will benefit from Neptune's presence and NKO(TM) recognition, as well as, the popularity of Glucosamine, in the occidental market" added Taro Terashi.

"The Koyo Chemical deal is an important one, they have the most extensive distribution network in Japan, through drug stores, direct sales, retail food chain and health care practitioners which reaches 127 Million consumers," said Gang He, Director of Sales, Asia for Neptune Technologies & Bioressources Inc. "More impressively, Koyo Chemical Ltd., was the first ever manufacturer of Glucosamine in Japan, and the first Japanese company to be Food Raw Material GMP certified. The new Glucosamine/NKO(TM) product, a powerful Joint Health Complex will rapidly cross the Japanese border, as the Neptune Koyo partnership has a reciprocal and mutual agreement, including the opportunity for Neptune to introduce the new Joint Health Complex with Glucosamine/NKO(TM), in North America and Europe," added Gang He.

About Neptune Technologies & Bioressources Inc.

Neptune Technologies & Bioressources Inc. develops high value added nutritional products from underexploited marine biomasses, such as krill, with its patented extraction process; Neptune OceanExtract(TM). Using our exclusive process, Neptune Technologies & Bioressources Inc. is well positioned in the $182 billion global nutrition market (Nutrition Business Journal, Oct/Nov 2004) of health and wellness concepts. Natural biomass extraction is now playing an important role in developing nutrigenomics, the next wave in nutritional research. Through strategic alliances and partnerships, as well as through clinical studies, the company continues to demonstrate the immense beneficial effects of these products. The company develops and markets new formulas and new products for specific applications in high growth markets such as the nutraceutical, cosmeceutical, biopharmaceutical and nutrigenomics markets.

For more information, call http://www.neptunebiotech.com.

COPYRIGHT 2006 Worldwide Videotex
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2023 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Worldwide Biotech
Date:Feb 1, 2006
Words:402
Previous Article:SANOFI-AVENTIS/REGENERON EXPAND VEGF TRAP PACT TO JAPAN.
Next Article:SHIRE GETS FDA APPROVABLE LETTER FOR DAYTRANA FOR ADHD.


Related Articles
GLUCOSAMINE & ARTHRITIS.
Update on arthritis.
Glucosamine versus placebo--dead even.
Arthritis alert.
Glucosamine isn't at fault.
Arthritis fighters: do glucosamine & chondroitin work?
Skepticism for glucosamine to treat OA pain.

Terms of use | Privacy policy | Copyright © 2024 Farlex, Inc. | Feedback | For webmasters |